Nomfundo Vilakazi has been appointed as Dis-Chem’s new human resources director, effective 1 December 2024. Source: Supplied. Nomfundo Vilakazi, Dis-Chem's new HR director. Throughout her five ...

Dis-Chem has named Nomfundo Vilakazi its new HR Director, effective 1 December 2024. Vilakazi, a seasoned HR leader with five years at Dis-Chem, most recently served as Head of HR Centres of ...

15 Is Nasal Spray Addictive? The National Institute of Drug Abuse defines drug addiction as a persistent neurological condition that leads to an uncontrollable reliance on drugs, even when the use ...

The Dis-Chem Foundation launched its first hydroponic vegetable garden, marking an important step in its commitment to address nutritional needs within underprivileged communities in the country.

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation ...

Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored at room temperature and administered as a nasal spray Prof. Ronit Satchi ...

Whether you’re just getting started or looking to elevate your regimen, Dis-Chem offers a wide range of face care products to help you achieve your skincare goals. Men’s grooming routines have evolved ...

Walt Disney (DIS) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue ...

Kalshi CEO Tarek Mansour confirmed on a podcast interview that his employees asked social media influencers to promote memes about the FBI’s raid on the home of his archrival, the CEO of Polymarket.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...